Skip to main content
. 2022 Sep 16;11(18):2901. doi: 10.3390/cells11182901

Figure 4.

Figure 4

Neutrophil phenotype in COVID-19. Expression of cell surface markers on neutrophils from AMC (n = 26), COVID-19 patients (n = 34) or CAP patients (n = 16) measured by flow cytometry. Data shows % cells expressing CD11b (A) p = 0.00014, MFI of CD11b (B) p = 0.0026, % expression of CD54 (C) p = <0.0001 and MFI of PD-L1 (D) p = 0.006 in AMC (n = 28), COVID-19 patients (n = 34), CAP patients (n = 16). Data were analysed by one way ANOVA. Expression of CXCR2 (E) p = 0.0322, CXCR4 (F) p = 0.0273 and % expression of CD54 (G) p = 0.0420) on COVID-19 neutrophils on day one or follow up (day three to five). Data are expressed as individual points, analyzed by Wilcoxon test (n = 11). * p < 0.05, ** p < 0.001, *** p < 0.0001.